{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:41:36Z","timestamp":1794361296086,"version":"4.9.0"},"publisher-location":"New York, NY","reference-count":80,"publisher":"Springer New York","isbn-type":[{"value":"9780387775739","type":"print"},{"value":"9780387775746","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1007\/978-0-387-77574-6_22","type":"book-chapter","created":{"date-parts":[[2009,1,7]],"date-time":"2009-01-07T09:43:07Z","timestamp":1231321387000},"page":"283-295","source":"Crossref","is-referenced-by-count":51,"title":["Apoptosis and Pathogenesis of Melanoma and Nonmelanoma Skin Cancer"],"prefix":"10.1007","author":[{"given":"Peter","family":"Erb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingmin","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwin","family":"Kump","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ainhoa","family":"Mielgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Wernli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"12","key":"22_CR1","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1038\/nm1518","volume":"12","author":"K. Loser","year":"2006","unstructured":"Loser K, Mehling A, Locscr S et al. Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells. Nat Med 2006;12(12):1372\u20131379.","journal-title":"Nat Med"},{"issue":"10","key":"22_CR2","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1001\/archderm.133.10.1263","volume":"133","author":"D. Grossman","year":"1997","unstructured":"Grossman D, Leffell DJ. The molecular basis of nonmelanoma skin cancer: new understanding. Arch Dermatol 1997;133(10):1263\u20131270.","journal-title":"Arch Dermatol"},{"key":"22_CR3","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S0092-8674(00)81871-1","volume":"88","author":"A.J. Levine","year":"1997","unstructured":"Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997;88:323\u2013331.","journal-title":"Cell"},{"issue":"4","key":"22_CR4","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1083\/jcb.200608070","volume":"176","author":"E. Naik","year":"2007","unstructured":"Naik E, Michalak EM, Villunger A et al. Ultraviolet radiation triggers apoptosis of fibroblasts and skin keratinocytes mainly via the BH3-only protein Noxa. J Cell Biol 2007;176(4):415\u2013424.","journal-title":"J Cell Biol"},{"issue":"5429","key":"22_CR5","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1126\/science.285.5429.898","volume":"285","author":"L.L. Hill","year":"1999","unstructured":"Hill LL, Ouhtit A, Loughlin SM et al. Fas ligand: A sensor for DNA damage critical in skin cancer etiology. Science 1999;285(5429):898\u2013900.","journal-title":"Science"},{"key":"22_CR6","doi-asserted-by":"crossref","first-page":"D538","DOI":"10.2741\/A211","volume":"2","author":"H. Soehnge","year":"1997","unstructured":"Soehnge H, Ouhtit A, Ananthaswamy ON. Mechanisms of induction of skin cancer by UV radiation. Front Biosci 1997;2:D538\u2013D551.","journal-title":"Front Biosci"},{"issue":"6508","key":"22_CR7","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/372773a0","volume":"372","author":"A. Ziegler","year":"1994","unstructured":"Ziegler A, Jonason AS, LefFell DJ et al. Sunburn and p53 in the onset of skin cancer [see comments]. Nature 1994;372(6508):773\u2013776.","journal-title":"Nature"},{"issue":"29","key":"22_CR8","doi-asserted-by":"publisher","first-page":"4247","DOI":"10.1038\/sj.onc.1202789","volume":"18","author":"W. Jiang","year":"1999","unstructured":"Jiang W, Ananthaswamy HN, Muller HK et al. p53 protects against skin cancer induction by UV-B radiation. Oncogene 1999;18(29):4247\u20134253.","journal-title":"Oncogene"},{"issue":"1","key":"22_CR9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/ajmg.a.20495","volume":"123A","author":"M.M. Cohen Jr","year":"2003","unstructured":"Cohen MM, Jr. The hedgehog signaling network. Am J Med Genet 2003;123A(1):5\u201328.","journal-title":"Am J Med Genet"},{"issue":"6","key":"22_CR10","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/S0092-8674(00)81268-4","volume":"85","author":"H. Hahn","year":"1996","unstructured":"Hahn H, Wicking C, Zaphiropoulous PG et al. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 1996;85(6):841\u2013851.","journal-title":"Cell"},{"issue":"5268","key":"22_CR11","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1126\/science.272.5268.1668","volume":"272","author":"R.L. Johnson","year":"1996","unstructured":"Johnson RL, Rothman AL, Xie J et al. Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 1996;272(5268):1668\u20131671.","journal-title":"Science"},{"issue":"6605","key":"22_CR12","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/384129a0","volume":"384","author":"D.M. Stone","year":"1996","unstructured":"Stone DM, Hynes M, Armanini M et al. The tumour-suppressor gene patched encodes a candidate receptor for Sonic hedgehog. Nature 1996;384(6605):129\u2013134.","journal-title":"Nature"},{"issue":"3","key":"22_CR13","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/73417","volume":"24","author":"M. Grachtchouk","year":"2000","unstructured":"Grachtchouk M, Mo R, Yu S et al. Basal cell carcinomas in mice overexpressing Gli2 in skin. Nat Genet 2000;24(3):216\u2013217.","journal-title":"Nat Genet"},{"issue":"5129","key":"22_CR14","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1126\/science.8378770","volume":"261","author":"N.P. Pavletich","year":"1993","unstructured":"Pavletich NP, Pabo CO. Crystal structure of a five-finger GLI-DNA complex: new perspectives on zinc fingers. Science 1993;261(5129):1701\u20131707.","journal-title":"Science"},{"issue":"5","key":"22_CR15","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.ygeno.2005.12.003","volume":"87","author":"T. Eichberger","year":"2006","unstructured":"Eichberger T, Sander V, Schnidar H et al. Overlapping and distinct transcriptional regulator properties of the GLI1 and GLI2 oncogenes. Genomics 2006;87(5):616\u2013632.","journal-title":"Genomics"},{"issue":"1","key":"22_CR16","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1006\/dbio.1996.0300","volume":"180","author":"V. Marigo","year":"1996","unstructured":"Marigo V, Johnson RL, Vortkamp A et al. Sonic hedgehog differentially regulates expression of GLI and GLI3 during limb development. Dev Biol 1996;180(1):273\u2013283.","journal-title":"Dev Biol"},{"issue":"13","key":"22_CR17","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1242\/dev.124.13.2537","volume":"124","author":"J. Lee","year":"1997","unstructured":"Lee J, Piatt KA, Censullo P et al. GUI is a target of Sonic hedgehog that induces ventral neural tube development. Development 1997;124(13):2537\u20132552.","journal-title":"Development"},{"issue":"6653","key":"22_CR18","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1038\/39918","volume":"389","author":"N. Dahmane","year":"1997","unstructured":"Dahmane N, Lee J, Robins P et al. Activation of the transcription factor Glil and the Sonic hedgehog signalling pathway in skin tumours. Nature 1997;389(6653):876\u2013881.","journal-title":"Nature"},{"issue":"7","key":"22_CR19","doi-asserted-by":"publisher","first-page":"3438","DOI":"10.1073\/pnas.050467397","volume":"97","author":"M. Nilsson","year":"2000","unstructured":"Nilsson M, Unden AB, Krause D et al. Induction of basal cell carcinomas and trichoepitheliomas in mice overexpressing GLI-1. Proc Natl Acad Sci USA 2000;97(7):3438\u20133443.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"18","key":"22_CR20","first-page":"5308","volume":"62","author":"H. Sheng","year":"2002","unstructured":"Sheng H, Goich S, Wang A et al. Dissecting the oncogenic potential of Gli:2 deletion of an NH(2)-terminal fragment alters skin tumor phenotype. Cancer Res 2002;62(18):5308\u20135316.","journal-title":"Cancer Res"},{"issue":"6599","key":"22_CR21","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/383407a0","volume":"383","author":"C. Chiang","year":"1996","unstructured":"Chiang C, Litingtung Y, Lee E et al. Cyclopia and defective axial patterning in mice lacking Sonic hedgehog gene function. Nature 1996;383(6599):407\u2013413.","journal-title":"Nature"},{"issue":"14","key":"22_CR22","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1242\/dev.125.14.2533","volume":"125","author":"Q. Ding","year":"1998","unstructured":"Ding Q, Motoyama J, Gasca S et al. Diminished Sonic hedgehog signaling and lack of floor plate differentiation in Gli2 mutant mice. Development 1998;125(14):2533\u20132543.","journal-title":"Development"},{"issue":"8","key":"22_CR23","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1242\/dev.127.8.1593","volume":"127","author":"H.L. Park","year":"2000","unstructured":"Park HL, Bai C, Platt KA et al. Mouse Glil mutants are viable but have defects in SHH signaling in combination with a Gli2 mutation. Development 2000;127(8):1593\u20131605.","journal-title":"Development"},{"issue":"2","key":"22_CR24","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1101\/gad.1038103","volume":"17","author":"P. Mill","year":"2003","unstructured":"Mill P, Mo R, Fu H et al. Sonic hedgehog-dependent activation of Gli2 is essential for embryonic hair follicle development. Genes Dev 2003;17(2):282\u2013294.","journal-title":"Genes Dev"},{"issue":"3","key":"22_CR25","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/j.1600-0749.2005.00235.x","volume":"18","author":"N.K. Haass","year":"2005","unstructured":"Haass NK, Smalley KS, Li L et al. Adhesion, migration and communication in melanocytes and melanoma. Pigment Cell Res 2005;18(3):150\u2013159.","journal-title":"Pigment Cell Res"},{"issue":"12","key":"22_CR26","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/S0046-8177(84)80310-X","volume":"15","author":"W.H. Clark Jr.","year":"1984","unstructured":"Clark WH, Jr., Elder DE, Guerry Dt et al. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Hum Pathol 1984;15(12):1147\u20131165.","journal-title":"Hum Pathol"},{"issue":"11","key":"22_CR27","first-page":"1363","volume":"4","author":"A.P. Albino","year":"1989","unstructured":"Albino AP, Nanus DM, Mentle IR et al. Analysis of ras oncogenes in malignant melanoma and precursor lesions: correlation of point mutations with differentiation phenotype. Oncogene 1989;4(11):1363\u20131374.","journal-title":"Oncogene"},{"issue":"6892","key":"22_CR28","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/nature00766","volume":"417","author":"H. Davies","year":"2002","unstructured":"Davies H, Bignell GR, Cox C, et al. Mutations of the BRAF gene in human cancer. Nature 2002;417(6892):949\u2013954.","journal-title":"Nature"},{"issue":"17","key":"22_CR29","first-page":"6483","volume":"9","author":"K. Omholt","year":"2003","unstructured":"Omholt K, Platz A, Kanter L et al. NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression. Clin Cancer Res 2003;9(17):6483\u20136488.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"22_CR30","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/ijc.20873","volume":"115","author":"M. Eskandarpour","year":"2005","unstructured":"Eskandarpour M, Kiaii S, Zhu C et al. Suppression of oncogenic NRAS by RNA interference induces apoptosis of human melanoma cells. Int J Cancer 2005;115(1):65\u201373.","journal-title":"Int J Cancer"},{"issue":"17","key":"22_CR31","first-page":"5198","volume":"63","author":"S.R. Hingorani","year":"2003","unstructured":"Hingorani SR, Jacobetz MA, Robertson GP et al. Suppression of BRAF(V599E) in human melanoma abrogates transformation. Cancer Res 2003;63(17):5198\u20135202.","journal-title":"Cancer Res"},{"issue":"9460","key":"22_CR32","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(05)70937-5","volume":"365","author":"J.F. Thompson","year":"2005","unstructured":"Thompson JF, Scolyer RA, Kefford RF. Cutaneous melanoma. Lancet 2005;365(9460):687\u2013701.","journal-title":"Lancet"},{"issue":"20","key":"22_CR33","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1038\/sj.onc.1206451","volume":"22","author":"H. Wu","year":"2003","unstructured":"Wu H, Goel V, Haluska FG. PTEN signaling pathways in melanoma. Oncogene 2003;22(20):3113\u20133122.","journal-title":"Oncogene"},{"issue":"20","key":"22_CR34","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1038\/sj.onc.1206461","volume":"22","author":"E. Sharpless","year":"2003","unstructured":"Sharpless E, Chin L. The INK4a\/ARF locus and melanoma. Oncogene 2003;22(20):3092\u20133098.","journal-title":"Oncogene"},{"issue":"8","key":"22_CR35","doi-asserted-by":"publisher","first-page":"4240","DOI":"10.1073\/pnas.96.8.4240","volume":"96","author":"L.C. Cantley","year":"1999","unstructured":"Cantley LC, Neel BG. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase\/AKT pathway. Proc Natl Acad Sci USA 1999;96(8):4240\u20134245.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"22_CR36","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/0092-8674(93)90429-T","volume":"74","author":"C.A. Hodgkinson","year":"1993","unstructured":"Hodgkinson CA, Moore KJ, Nakayama A et al. Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein. Cell 1993;74(2):395\u2013404.","journal-title":"Cell"},{"issue":"18","key":"22_CR37","first-page":"5012","volume":"60","author":"G.I. Salti","year":"2000","unstructured":"Salti GI, Manougian T, Farolan M et al. Micropthalmia transcription factor: a new prognostic marker in intermediate-thickness cutaneous malignant melanoma. Cancer Res 2000;60(18):5012\u20135016.","journal-title":"Cancer Res"},{"issue":"7047","key":"22_CR38","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nature03664","volume":"436","author":"L.A. Garraway","year":"2005","unstructured":"Garraway LA, Widlund HR, Rubin MA et al. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature 2005;436(7047):117\u2013122.","journal-title":"Nature"},{"issue":"2","key":"22_CR39","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s10555-005-1572-1","volume":"24","author":"S. Kuphal","year":"2005","unstructured":"Kuphal S, Bauer R, Bosserhoff AK. Integrin signaling in malignant melanoma. Cancer Metastasis Rev 2005;24(2):195\u2013222.","journal-title":"Cancer Metastasis Rev"},{"issue":"3","key":"22_CR40","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1365-2559.1994.tb00517.x","volume":"24","author":"E.H. Danen","year":"1994","unstructured":"Danen EH, Ten Berge PJ, Van Muijen GN et al. Emergence of alpha 5 beta 1 fibronectin-and alpha v beta 3 vitronectin-receptor expression in melanocytic tumour progression. Histopathology 1994;24(3):249\u2013256.","journal-title":"Histopathology"},{"issue":"11","key":"22_CR41","first-page":"2724","volume":"59","author":"E. Petitclerc","year":"1999","unstructured":"Petitclerc E, Stromblad S, von Schalscha TL et al. Integrin alpha(v)beta3 promotes M21 melanoma growth in human skin by regulating tumor cell survival. Cancer Res 1999;59(11):2724\u20132730.","journal-title":"Cancer Res"},{"issue":"1","key":"22_CR42","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1056\/NEJMra052166","volume":"355","author":"A.J. Miller","year":"2006","unstructured":"Miller AJ, Mihm Jr MC, Melanoma. N Engl J Med 2006;355(1):51\u201365.","journal-title":"N Engl J Med"},{"key":"22_CR43","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1146\/annurev.immunol.24.021605.090733","volume":"24","author":"T. Boon","year":"2006","unstructured":"Boon T, Coulie PG, Van den Eynde BJ et al. Human T-cell responses against melanoma. Annu Rev Immunol 2006;24:175\u2013208.","journal-title":"Annu Rev Immunol"},{"issue":"5","key":"22_CR44","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1023\/A:1025319031417","volume":"23","author":"A. Bhardwaj","year":"2003","unstructured":"Bhardwaj A, Aggarwal BB. Receptor-mediated choreography of life and death. J Clin Immunol 2003;23(5):317\u2013332.","journal-title":"J Clin Immunol"},{"issue":"23","key":"22_CR45","doi-asserted-by":"publisher","first-page":"14363","DOI":"10.1074\/jbc.273.23.14363","volume":"273","author":"J.G. Emery","year":"1998","unstructured":"Emery JG, McDonnell P, Burke MB et al. Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. J Biol Chem 1998;273(23):14363\u201314367.","journal-title":"J Biol Chem"},{"key":"22_CR46","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1146\/annurev.genet.33.1.29","volume":"33","author":"S. Nagata","year":"1999","unstructured":"Nagata S. Fas ligand-induccd apoptosis. Annu Rev Genet 1999;33:29\u201355.","journal-title":"Annu Rev Genet"},{"issue":"6805","key":"22_CR47","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/35037728","volume":"407","author":"P.H. Krammer","year":"2000","unstructured":"Krammer PH. CD95\u2019s deadly mission in the immune system. Nature 2000;407(6805):789\u2013795.","journal-title":"Nature"},{"issue":"2\u20133","key":"22_CR48","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.bbamcr.2003.08.009","volume":"1644","author":"V. Kirkin","year":"2004","unstructured":"Kirkin V, Joos S, Zornig M. The role of Bcl-2 family members in tumorigenesis. Biochim Biophys Acta 2004;1644(2\u20133):229\u2013249.","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"22_CR49","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S0092-8674(00)81590-1","volume":"94","author":"H.L. Li","year":"1998","unstructured":"Li HL, Zhu H, Xu CJ et al. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 1998;94(4):491\u2013501.","journal-title":"Cell"},{"issue":"11","key":"22_CR50","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1038\/sj\/leu\/2401333","volume":"13","author":"C. Friesen","year":"1999","unstructured":"Friesen C, Fulda S, Debatin KM. Cytotoxic drugs and the CD95 pathway. Leukemia 1999;13(11):1854\u20131858.","journal-title":"Leukemia"},{"issue":"5291","key":"22_CR51","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1126\/science.274.5291.1363","volume":"274","author":"M. Hahne","year":"1996","unstructured":"Hahne M, Rimoldi D, Schroter M et al. Melanoma cell expression of Fas(Apo-1\/CD95) ligand: implications for tumor immune escape [see comments]. Science 1996;274(5291):1363\u20131366.","journal-title":"Science"},{"issue":"4","key":"22_CR52","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nrc776","volume":"2","author":"F.H. Igney","year":"2002","unstructured":"Igney FH, Krammer PH. Death and anti-death: Tumor resistance to apoptosis. Nat Rev Cancer 2002;2(4):277\u2013288.","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"22_CR53","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.4049\/jimmunol.161.6.2833","volume":"161","author":"T.S. Griffith","year":"1998","unstructured":"Griffith TS, Chin WA, Jackson GC et al. Intracellular regulation of TRAJL-induced apoptosis in human melanoma cells. J Immunol 1998;161(6):2833\u20132840.","journal-title":"J Immunol"},{"issue":"11","key":"22_CR54","first-page":"2747","volume":"59","author":"X.D. Zhang","year":"1999","unstructured":"Zhang XD, Franco A, Myers K et al. Relation of TNF-related apoptosis-inducing ligand (TRAIL) receptor and FLICE-inhibitory protein expression to TRAIL-induced apoptosis of melanoma. Cancer Res 1999;59(11):2747\u20132753.","journal-title":"Cancer Res"},{"issue":"12","key":"22_CR55","doi-asserted-by":"publisher","first-page":"3856","DOI":"10.1158\/1078-0432.CCR-06-0190","volume":"12","author":"M.M. McCarthy","year":"2006","unstructured":"McCarthy MM, DiVito KA, Sznol M et al. Expression of Tumor Necrosis Factor-Related Apoptosis-inducing Ligand Receptors 1 and 2 in Melanoma. Clin Cancer Res 2006;12(12):3856\u20133863.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"22_CR56","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1046\/j.1365-2133.2000.03655.x","volume":"143","author":"C. Soubrane","year":"2000","unstructured":"Soubrane C, Mouawad R, Antoine EC et al. A comparative study of Fas and Fas-ligand expression during melanoma progression. Brit J Dermatol 2000;143(2):307\u2013312.","journal-title":"Brit J Dermatol"},{"issue":"10","key":"22_CR57","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/j.humpath.2006.04.026","volume":"37","author":"L. Zhuang","year":"2006","unstructured":"Zhuang L, Lee CS, Scolyer RA et al. Progression in melanoma is associated with decreased expression of death receptors for tumor necrosis factor-related apoptosis-inducing ligand. Human Pathology 2006;37(10):1286\u20131294.","journal-title":"Human Pathology"},{"issue":"5","key":"22_CR58","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/ijc.1378","volume":"93","author":"H. Helmbach","year":"2001","unstructured":"Helmbach H, Rossmann E, Kern MA et al. Drug-resistance in human melanoma. Int J Cancer 2001;93(5):617\u2013622.","journal-title":"Int J Cancer"},{"issue":"11","key":"22_CR59","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1172\/JCI119814","volume":"100","author":"S.A. Buechner","year":"1997","unstructured":"Buechner SA, Wernli M, Harr T et al. Regression of basal cell carcinoma by intralesional interferon-alpha treatment is mediated by CD95 (Apo-1\/Fas)-CD95 ligand-induced suicide. J Clin Invest 1997;100(11):2691\u20132696.","journal-title":"J Clin Invest"},{"issue":"1","key":"22_CR60","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1172\/JCI1165","volume":"101","author":"C. GutierrezSteil","year":"1998","unstructured":"GutierrezSteil C, WroneSmith T, Sun XM et al. Sunlight-induced basal cell carcinoma tumor cells and ultraviolet-B-irradiated psoriatic plaques express Fas ligand (CD95L). J Clin Invest 1998;101(1):33\u201339.","journal-title":"J Clin Invest"},{"issue":"1","key":"22_CR61","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1046\/j.0022-202x.2001.01380.x","volume":"117","author":"F. Bachmann","year":"2001","unstructured":"Bachmann F, Buechner SA, Wernli M et al. Ultraviolet light downregulates CD95 ligand and trail receptor expression facilitating actinic keratosis and squamous cell carcinoma formation. J Invest Dermatol 2001;117(1):59\u201366.","journal-title":"J Invest Dermatol"},{"issue":"2","key":"22_CR62","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/01.dad.0000154401.45465.ee","volume":"27","author":"S. Stander","year":"2005","unstructured":"Stander S, Schwarz T. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is expressed in normal skin and cutaneous inflammatory diseases, but not in chronically UV-exposed skin and nonmelanoma skin cancer. Am J Dermatopathol 2005;27(2):116\u2013121.","journal-title":"Am J Dermatopathol"},{"issue":"18","key":"22_CR63","doi-asserted-by":"publisher","first-page":"6775","DOI":"10.1158\/0008-5472.CAN-04-0508","volume":"64","author":"K. Hallermalm","year":"2004","unstructured":"Hallermalm K, De Geer A, Kiessling R et al. Secretion of Fas Ligand Shields Tumor Cells from Fas-Mediated Killing by Cytotoxic Lymphocytes. Cancer Res 2004;64(18):6775\u20136782.","journal-title":"Cancer Res"},{"issue":"2","key":"22_CR64","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0955-0674(99)80034-9","volume":"11","author":"A. Ashkenazi","year":"1999","unstructured":"Ashkenazi A, Dixit VM. Apoptosis control by death and decoy receptors. Curr Opin Cell Biol 1999;11(2):255\u2013260.","journal-title":"Curr Opin Cell Biol"},{"issue":"1","key":"22_CR65","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/sj.cdd.4401187","volume":"10","author":"H.N. LeBlanc","year":"2003","unstructured":"LeBlanc HN, Ashkenazi A. Apo2L\/TRAIL and its death and decoy receptors. Cell Death Differentiation 2003;10(1):66\u201375.","journal-title":"Cell Death Differentiation"},{"issue":"3","key":"22_CR66","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0014-5793(00)02042-1","volume":"482","author":"X.D. Zhang","year":"2000","unstructured":"Zhang XD, Nguyen T, Thomas WD et al. Mechanisms of resistance of normal cells to TRAIL induced apoptosis vary between different cell types. Febs Lett 2000;482(3):193\u2013199.","journal-title":"Febs Lett"},{"issue":"6","key":"22_CR67","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/S1074-7613(00)80401-X","volume":"7","author":"P. Schneider","year":"1997","unstructured":"Schneider P, Thome M, Burns K et al. TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappa B. Immunity 1997;7(6):831\u2013836.","journal-title":"Immunity"},{"issue":"2","key":"22_CR68","first-page":"335","volume":"6","author":"K. Kim","year":"2000","unstructured":"Kim K, Fisher MJ, Xu SQ et al. Molecular determinants of response to TRAIL in killing of normal and cancer cells. Clin Cancer Res 2000;6(2):335\u2013346.","journal-title":"Clin Cancer Res"},{"key":"22_CR69","doi-asserted-by":"crossref","unstructured":"Kurbanov BM, Fecker LF, Geilen CC et al. Resistance of melanoma cells to TRAIL does not result from upregulation of antiapoptotic proteins by NF-[kappa]B but is related to downregulation of initiator caspases and DR4. Oncogene 2006.","DOI":"10.1038\/sj.onc.1210134"},{"issue":"5","key":"22_CR70","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.4049\/jimmunol.161.5.2195","volume":"161","author":"W.D. Thomas","year":"1998","unstructured":"Thomas WD, Hersey P. TNF-related apoptosis-inducing ligand (TRAIL) induces apoptosis in Fas ligand-resistant melanoma cells and mediates CD4 T-cell killing of target cells. J Immunol 1998;161(5):2195\u20132200.","journal-title":"J Immunol"},{"issue":"2","key":"22_CR71","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/5517","volume":"5","author":"H. Walczak","year":"1999","unstructured":"Walczak H, Miller RE, Ariail K et al. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo [see comments]. Nat Med 1999;5(2):157\u2013163.","journal-title":"Nat Med"},{"issue":"8","key":"22_CR72","first-page":"3330","volume":"61","author":"S. Kagawa","year":"2001","unstructured":"Kagawa S, He C, Gu J et al. Antitumor activity and bystander effects of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene. Cancer Res 2001;61(8):3330\u20133338.","journal-title":"Cancer Res"},{"issue":"8","key":"22_CR73","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/sj.gt.3302453","volume":"12","author":"J. Ji","year":"2005","unstructured":"Ji J, Wernli M, Mielgo A et al. Fas-ligand gene silencing in basal cell carcinoma tissue with small interfering RNA. Gene Ther 2005;12(8):678\u2013684.","journal-title":"Gene Ther"},{"issue":"6","key":"22_CR74","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1046\/j.1523-1747.2003.12256.x","volume":"120","author":"J. Ji","year":"2003","unstructured":"Ji J, Wernli M, Bucchner S et al. Fas ligand downregulation with antiscnsc oligonucleotides in cells and in cultured tissues of normal skin epidermis and basal cell carcinoma. J Invest Dermatol 2003;120(6):1094\u20131099.","journal-title":"J Invest Dermatol"},{"issue":"21","key":"22_CR75","doi-asserted-by":"publisher","first-page":"7724","DOI":"10.1158\/0008-5472.CAN-04-1085","volume":"64","author":"G. Regl","year":"2004","unstructured":"Regl G, Kasper M, Schnidar H et al. Activation of the BCL2 promoter in response to Hedgehog\/GLI signal transduction is predominantly mediated by GLI2. Cancer Res 2004;64(21):7724\u20137731.","journal-title":"Cancer Res"},{"issue":"2","key":"22_CR76","first-page":"360","volume":"117","author":"R.R. Bullani","year":"2001","unstructured":"Bullani RR, Huard B, Viard-Leveugle I et al. Selective Expression of FLIP in Malignant Melanocytic Skin Lesions 2001;117(2):360\u2013364.","journal-title":"Selective Expression of FLIP in Malignant Melanocytic Skin Lesions"},{"issue":"4","key":"22_CR77","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1111\/j.0022-202X.2004.23420.x","volume":"123","author":"E. Zeise","year":"2004","unstructured":"Zeise E, Weichenthal M, Schwarz T et al. Resistance of Human Melanoma Cells Against the Death Ligand TRAIL Is Reversed by Ultraviolet-B Radiation via Downregulation of FLIP. J Investig Dermatol 2004;123(4):746\u2013754.","journal-title":"J Investig Dermatol"},{"issue":"8","key":"22_CR78","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/sj.cdd.4401416","volume":"11","author":"M. Chawla-Sarkar","year":"2004","unstructured":"Chawla-Sarkar M, Bae SI, Reu FJ et al. Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L\/TRAIL-induced apoptosis. Cell Death Differ 2004;11(8):915\u2013923.","journal-title":"Cell Death Differ"},{"issue":"20","key":"22_CR79","doi-asserted-by":"publisher","first-page":"4120","DOI":"10.1016\/j.yexcr.2006.09.019","volume":"312","author":"V.N. Ivanov","year":"2006","unstructured":"Ivanov VN, Hei TK. Sodium arsenite accelerates TRAIL-mediated apoptosis in melanoma cells through upregulation of TRAIL-R1\/R2 surface levels and downregulation of cFLIP expression. Experimental Cell Research 2006;312(20):4120\u20134138.","journal-title":"Experimental Cell Research"},{"issue":"5","key":"22_CR80","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1002\/jcb.20844","volume":"98","author":"Y.J.L. Young-Ho Kim","year":"2006","unstructured":"Young-Ho Kim YJL. Time sequence of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and cisplatin treatment is responsible for a complex pattern of synergistic cytotoxicity. Journal of Cellular Biochemistry 2006;98(5):1284\u20131295.","journal-title":"Journal of Cellular Biochemistry"}],"container-title":["Advances in Experimental Medicine and Biology","Sunlight, Vitamin D and Skin Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-0-387-77574-6_22.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T10:33:19Z","timestamp":1684837999000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-0-387-77574-6_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[null]]},"ISBN":["9780387775739","9780387775746"],"references-count":80,"URL":"https:\/\/doi.org\/10.1007\/978-0-387-77574-6_22","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-0-387-77574-6","asserted-by":"object"}]},"ISSN":["0065-2598"],"issn-type":[{"value":"0065-2598","type":"print"}],"subject":[]}}